{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T09:32:27Z","timestamp":1740130347668,"version":"3.37.3"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"3","funder":[{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["14411962400"],"award-info":[{"award-number":["14411962400"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3,1]]},"DOI":"10.1093\/jjco\/hyx183","type":"journal-article","created":{"date-parts":[[2017,11,29]],"date-time":"2017-11-29T17:48:36Z","timestamp":1511977716000},"page":"265-271","source":"Crossref","is-referenced-by-count":5,"title":["Impact of minimum point dose on local control and toxicity in T3\u20134 nasopharyngeal carcinoma treated with intensity-modulated radiation therapy plus chemotherapy"],"prefix":"10.1093","volume":"48","author":[{"given":"Fen","family":"Xue","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Fudan University Shanghai Cancer Center"},{"name":"Department of Oncology, Shanghai Medical College, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaosu","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Fudan University Shanghai Cancer Center"},{"name":"Department of Oncology, Shanghai Medical College, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1652-3012","authenticated-orcid":false,"given":"Xiayun","family":"He","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Fudan University Shanghai Cancer Center"},{"name":"Department of Oncology, Shanghai Medical College, Shanghai, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,12,26]]},"reference":[{"key":"key\n\t\t\t\t20180830004412_hyx183C1","first-page":"377","article-title":"Evolution of treatment for nasopharyngeal cancer \u2013 success and setback in the intensity-modulated radiotherapy era","volume":"110","author":"Lee","year":"2014","journal-title":"Radiother Oncol"},{"key":"key\n\t\t\t\t20180830004412_hyx183C2","first-page":"3356","article-title":"Management of nasopharyngeal carcinoma: current practice and future perspective","volume":"33","author":"Lee","year":"2015","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20180830004412_hyx183C3","first-page":"623","article-title":"Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer","volume":"49","author":"Hunt","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key\n\t\t\t\t20180830004412_hyx183C4","first-page":"145","article-title":"Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation","volume":"56","author":"Kam","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key\n\t\t\t\t20180830004412_hyx183C5","first-page":"57","article-title":"Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan\u2013Kettering experience","volume":"64","author":"Wolden","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key\n\t\t\t\t20180830004412_hyx183C6","first-page":"661","article-title":"How does intensity-modulated radiotherapy versus conventional two-dimensional radiotherapy influence the treatment results in nasopharyngeal carcinoma patients?","volume":"80","author":"Lai","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key\n\t\t\t\t20180830004412_hyx183C7","first-page":"327","article-title":"Long-term outcomes of early-stage nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy alone","volume":"82","author":"Su","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key\n\t\t\t\t20180830004412_hyx183C8","first-page":"106","article-title":"Concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: treatment outcomes of a prospective, multicentric clinical study","volume":"112","author":"Wu","year":"2014","journal-title":"Radiother Oncol"},{"key":"key\n\t\t\t\t20180830004412_hyx183C9","first-page":"163","article-title":"Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial","volume":"13","author":"Chen","year":"2012","journal-title":"Lancet Oncol"},{"key":"key\n\t\t\t\t20180830004412_hyx183C10","first-page":"645","article-title":"Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis","volume":"16","author":"Blanchard","year":"2015","journal-title":"Lancet Oncol"},{"key":"key\n\t\t\t\t20180830004412_hyx183C11","first-page":"1509","article-title":"Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial","volume":"17","author":"Sun","year":"2016","journal-title":"Lancet Oncol"},{"key":"key\n\t\t\t\t20180830004412_hyx183C12","first-page":"398","article-title":"Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities","volume":"110","author":"Sun","year":"2014","journal-title":"Radiother Oncol"},{"key":"key\n\t\t\t\t20180830004412_hyx183C13","first-page":"233","article-title":"Current management of nasopharyngeal cancer","volume":"22","author":"Lee","year":"2012","journal-title":"Semin Radiat Oncol"},{"key":"key\n\t\t\t\t20180830004412_hyx183C14","first-page":"374","article-title":"Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma","volume":"64","author":"Kwong","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key\n\t\t\t\t20180830004412_hyx183C15","first-page":"401","article-title":"Dose escalation for patients with locally advanced nasopharyngeal carcinoma treated with radiotherapy alone","volume":"30","author":"Yeh","year":"2007","journal-title":"Am J Clin Oncol"},{"key":"key\n\t\t\t\t20180830004412_hyx183C16","first-page":"1471","article-title":"The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM","volume":"17","author":"Edge","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"key\n\t\t\t\t20180830004412_hyx183C17","first-page":"3684","article-title":"Intensity-modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225","volume":"27","author":"Lee","year":"2009","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20180830004412_hyx183C18","first-page":"176","article-title":"CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment","volume":"13","author":"Trotti","year":"2003","journal-title":"Semin Radiat Oncol"},{"key":"key\n\t\t\t\t20180830004412_hyx183C19","first-page":"1341","article-title":"Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key\n\t\t\t\t20180830004412_hyx183C20","first-page":"228","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"key\n\t\t\t\t20180830004412_hyx183C21","first-page":"286","article-title":"A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma","volume":"104","author":"Peng","year":"2012","journal-title":"Radiother Oncol"},{"key":"key\n\t\t\t\t20180830004412_hyx183C22","first-page":"393","article-title":"Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy in patients with nasopharyngeal carcinoma","volume":"71","author":"Hara","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key\n\t\t\t\t20180830004412_hyx183C23","first-page":"204","article-title":"Potential improvement of tumor control probability by induction chemotherapy for advanced nasopharyngeal carcinoma","volume":"87","author":"Lee","year":"2008","journal-title":"Radiother Oncol"},{"key":"key\n\t\t\t\t20180830004412_hyx183C24","first-page":"71","article-title":"A phase III randomized study comparing neoadjuvant chemotherapy with concurrent chemotherapy combined with radiotherapy for locoregionally advanced nasopharyngeal carcinoma: updated long-term survival outcomes","volume":"50","author":"Xu","year":"2014","journal-title":"Oral Oncol"},{"key":"key\n\t\t\t\t20180830004412_hyx183C25","first-page":"153","article-title":"Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial","volume":"12","author":"Lorch","year":"2011","journal-title":"Lancet Oncol"},{"key":"key\n\t\t\t\t20180830004412_hyx183C26","first-page":"464","article-title":"Experience with combination of docetaxel, cisplatin plus 5-fluorouracil chemotherapy, and intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma","volume":"18","author":"Du","year":"2013","journal-title":"Int J Clin Oncol"},{"key":"key\n\t\t\t\t20180830004412_hyx183C27","first-page":"506","article-title":"The impact of dosimetric inadequacy on treatment outcome of nasopharyngeal carcinoma with IMRT","volume":"50","author":"Ng","year":"2014","journal-title":"Oral Oncol"},{"key":"key\n\t\t\t\t20180830004412_hyx183C28","first-page":"312","article-title":"Clinical and dosimetric characteristics of temporal lobe injury following intensity modulated radiotherapy of nasopharyngeal carcinoma","volume":"104","author":"Su","year":"2012","journal-title":"Radiother Oncol"},{"key":"key\n\t\t\t\t20180830004412_hyx183C29","first-page":"565","article-title":"Treatment outcomes for different subgroups of nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapy","volume":"30","author":"Su","year":"2011","journal-title":"Chin J Cancer"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jjco\/article-pdf\/48\/3\/265\/25535572\/hyx183.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T19:10:52Z","timestamp":1535656252000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/article\/48\/3\/265\/4774980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,26]]},"references-count":29,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,12,26]]},"published-print":{"date-parts":[[2018,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyx183","relation":{},"ISSN":["0368-2811","1465-3621"],"issn-type":[{"type":"print","value":"0368-2811"},{"type":"electronic","value":"1465-3621"}],"subject":[],"published-other":{"date-parts":[[2018,3]]},"published":{"date-parts":[[2017,12,26]]}}}